Journal profile · Medicine-Genetics (clinical)
Egyptian Journal of Medical Human Genetics
ISSN 1110-8630 · eISSN 2090-2441 · Springer Nature · United Kingdom
Egyptian Journal of Medical Human Genetics: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 1.3 (journal website); diamond open access (no APC); no APC; median 165 days to acceptance (103 articles, last 24 months); 200 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Egyptian Journal of Medical Human Genetics is published by Springer Nature and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, RNA modifications and cancer and Genomics and Rare Diseases, together about 18.4% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Egyptian Journal of Medical Human Genetics (EJMHG) is an open access, peer-reviewed journal with a focus on reporting innovations within the field of human and medical genetics. The journal considers articles on all aspects of the genetic basis of human disease, with a particular emphasis on biochemical genetics, biological studies of enzymes and other protein deficiencies, as well as immunogenetics. Other topics of interest include investigations of the pathogenesis of inherited disorders and practical advances in the molecular diagnosis of human disease. Articles presenting clinical applications of genomics and next generation sequencing technologies are considered valuable contributions. Egyptian Journal of Medical Human Genetics welcomes submissions of editorials, research, reviews, case reports, correspondence, meta-analysis and commentaries.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Genetics (clinical)
Editor-in-chief Solaf ElsayedPublisher website
Editorial board by country: 3 in mainland China (about 8%); most named Egypt 9, United States 4, India 4, Mainland China 3, Türkiye 2 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6.3%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.2%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology5.8%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.5%
- Hemoglobinopathies and Related DisordersMedicine5.5%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology5.2%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology4.9%
- Folate and B Vitamins ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.4Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.36LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 37OpenAlex ·
- i10-index
- 287OpenAlex ·
- 2-year mean citedness
- 1.74OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 195LetPub ·
- Downloads per year (publisher) 2025
- 659,600Publisher website ·
Articles by year OpenAlex count · 1,469 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 85 | 85 | 17 |
| 2025 | 200 | 200 | 243 |
| 2024 | 160 | 160 | 513 |
| 2023 | 87 | 87 | 329 |
| 2022 | 167 | 167 | 1,001 |
| 2021 | 92 | 92 | 679 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
165 daysMedian, submission to acceptance · P25–P75 118 days – 239 days
- Acceptance to online
- median 18 days (103 articles)
- Submission to online
- median 189 days
- Sample
- 103 articles with submission and acceptance dates (334 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Submission to first decision
- 22 daysPublisher website ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 0 | — | — | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence; authors retain copyright. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Egyptian Journal of Medical Human Genetics articles are published open access under a CC BY-NC-ND (Creative …
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review policy exists; details on external page. Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1110-8630
- Electronic ISSN
- 2090-2441
- Society / sponsor
- Egyptian Society of Human Genetics
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Egyptian Journal of Medical Human Genetics
What CAS zone is Egyptian Journal of Medical Human Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Egyptian Journal of Medical Human Genetics is in Zone 4 of Biology, and in Zone 4 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Egyptian Journal of Medical Human Genetics?
The journal's website gives an impact factor of 1.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.1, h-index 37.
How long does peer review take at Egyptian Journal of Medical Human Genetics?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 165 days (interquartile range 118–239 days); authors report an average review time of about 18 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Egyptian Journal of Medical Human Genetics based?
Of the 39 board members whose country the journal's board page names, 3 (about 8%) are in mainland China; the countries named most often are Egypt (9), United States (4) and India (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Egyptian Journal of Medical Human Genetics?
According to LetPub and DOAJ records, Egyptian Journal of Medical Human Genetics is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Egyptian Journal of Medical Human Genetics open access, and what is the APC?
Egyptian Journal of Medical Human Genetics is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .